Iconovo AB (publ.), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announces that it has agreed to conduct a feasibility study on behal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback